The sNDA was supported by data from a 4 week MUSE study and a long-term open-label study in children aged 2 to 5 years.

Prescription Drug User Fee Act (PDUFA) target action date set for June 29, 2026If approved, ZORYVE cream 0.3% would be the first and only topical ...

Biologic therapy use among patients with psoriatic disease was associated with a lower risk for malignancy compared with topical therapy use.

A study published in The New England Journal of Medicine has reported that the oral peptide icotrokinra, a selective ...

‘The Kardashians’ star looked back on some of the home remedies she tried for her psoriasis on the July 16 episode of the 'SHE MD' podcast Kim Kardashian/Instagram Kim Kardashian is looking back on ...

The novel, oral interleukin-23 inhibitor icotrokinra bested placebo in multiple skin outcomes among adolescent patients with ...

Discover key truths about psoriasis, from symptoms and causes to effective management strategies to improve your quality of ...

The treatment of psoriasis—an autoimmune disease that creates red, scaly plaques on the skin—depends on multiple factors, but two big factors include the severity and the location of the symptoms, ...

For the 7.5 million Americans diagnosed with psoriasis, it can be disheartening to hear that there's no cure. But there are several treatments that can help keep this autoimmune disease under control.

The global psoriasis treatment market is projected to expand at a compound annual growth rate (CAGR) of 8.5% by 2026. Key factors fueling this growth include the rising prevalence of psoriasis, ...

Researchers reviewed hormone variation, life cycles, and their effect on quality of life specific to women with psoriasis.

January's approval by the Food and Drug Administration (FDA) of Amevive, the first biologic treatment for chronic plaque psoriasis, is a qualified blessing for the estimated 1.5 million Americans who ...